These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2315370)

  • 1. Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum.
    Basse-Tomusk A; Rebec GV
    Pharmacol Biochem Behav; 1990 Jan; 35(1):55-60. PubMed ID: 2315370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine promotes neostriatal ascorbate release via a nigro-thalamo-cortico-neostriatal loop.
    Pierce RC; Clemens AJ; Grabner CP; Rebec GV
    J Neurochem; 1994 Oct; 63(4):1499-507. PubMed ID: 7931303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrastriatal infusions of ascorbate antagonize the behavioral response to amphetamine.
    White LK; Maurer M; Kraft ME; Oh C; Rebec GV
    Pharmacol Biochem Behav; 1990 Jul; 36(3):485-9. PubMed ID: 2377651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of lesions of the ventromedial nucleus of the thalamus on cerebral metabolism: experimental study in the rat using the 14C-deoxyglucose method].
    Girault JA; Savaki HE; Desban M; Glowinski J; Besson MJ
    Rev Neurol (Paris); 1986; 142(4):456-64. PubMed ID: 3787051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of cortical ablation on d-amphetamine-induced changes in striatal dopamine turnover and ascorbic acid catabolism in the rat.
    Desole MS; Miele M; Enrico P; Fresu L; Esposito G; De Natale G; Miele E
    Neurosci Lett; 1992 May; 139(1):29-33. PubMed ID: 1407680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo voltammetry with electrodes that discriminate between dopamine and ascorbate.
    Ewing AG; Wightman RM; Dayton MA
    Brain Res; 1982 Oct; 249(2):361-70. PubMed ID: 6814706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum.
    Wilson RL; Kamata K; Bigelow JC; Rebec GV; Wightman RM
    Brain Res; 1986 Apr; 370(2):393-6. PubMed ID: 3518863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of both D1- and D2-dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum.
    Oh C; Gardiner TW; Rebec GV
    Brain Res; 1989 Feb; 480(1-2):184-9. PubMed ID: 2565749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium-size spiny neurons in the rat neostriatum.
    Dubé L; Smith AD; Bolam JP
    J Comp Neurol; 1988 Jan; 267(4):455-71. PubMed ID: 3346370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and long-term amphetamine treatments alter extracellular ascorbate in neostriatum but not nucleus accumbens of freely moving rats.
    Yount SE; Kraft ME; Pierce RC; Langley PE; Rebec GV
    Life Sci; 1991; 49(17):1237-44. PubMed ID: 1943438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of haloperidol on amphetamine-induced increases in ascorbic acid and uric acid as determined by voltammetry in vivo.
    Mueller K; Haskett C
    Pharmacol Biochem Behav; 1987 Jun; 27(2):231-4. PubMed ID: 3628437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple amphetamine injections reduce the release of ascorbic acid in the neostriatum of the rat.
    Kamata K; Wilson RL; Alloway KD; Rebec GV
    Brain Res; 1986 Jan; 362(2):331-8. PubMed ID: 3942882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of both D1 and D2 dopamine receptors increases behavioral activation and ascorbate release in the neostriatum of freely moving rats.
    Pierce RC; Rebec GV
    Eur J Pharmacol; 1990 Dec; 191(3):295-302. PubMed ID: 1982267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-, NMDA- and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving rats.
    Pierce RC; Rebec GV
    Brain Res; 1992 May; 579(1):59-66. PubMed ID: 1352478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and nigral application of amphetamine both cause an increase in extracellular concentration of ascorbate in the caudate nucleus of the rat.
    Wilson RL; Wightman RM
    Brain Res; 1985 Jul; 339(2):219-26. PubMed ID: 4027622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lesion of corticostriatal fibers reduces GABAB but not GABAA binding in rat caudate putamen: an autoradiographic study.
    Moratalla R; Bowery NG
    Neurochem Res; 1991 Mar; 16(3):309-15. PubMed ID: 1664057
    [No Abstract]   [Full Text] [Related]  

  • 17. Repeated administration of high doses of amphetamine increases release of ascorbic acid in caudate but not nucleus accumbens.
    Mueller K
    Brain Res; 1989 Aug; 494(1):30-5. PubMed ID: 2765922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the parafascicular thalamic nucleus and N-methyl-D-aspartate transmission in the D1-dependent control of in vivo acetylcholine release in rat striatum.
    Consolo S; Baronio P; Guidi G; Di Chiara G
    Neuroscience; 1996 Mar; 71(1):157-65. PubMed ID: 8834399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral cortical ablations attenuate amphetamine-induced excitations of neostriatal motor-related neurons in freely moving rats.
    Tschanz JT; Haracz JL; Griffith KE; Rebec GV
    Neurosci Lett; 1991 Dec; 134(1):127-30. PubMed ID: 1815145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the bilateral corticostriatal glutamatergic projection by infusion of GABA into thalamic motor nuclei in the cat: an in vivo release study.
    Barbeito L; Girault JA; Godeheu G; Pittaluga A; Glowinski J; Cheramy A
    Neuroscience; 1989; 28(2):365-74. PubMed ID: 2564170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.